Src Drives Growth of Antiestrogen Resistant Breast Cancer Cell Lines and Is a Marker for Reduced Benefit of Tamoxifen Treatment

The underlying mechanisms leading to antiestrogen resistance in estrogen-receptor α (ER)-positive breast cancer is still poorly understood. The aim of this study was therefore to identify biomarkers and novel treatments for antiestrogen resistant breast cancer. We performed a kinase inhibitor screen...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:PLoS One
Main Authors: Larsen, Sarah L., Laenkholm, Anne-Vibeke, Duun-Henriksen, Anne Katrine, Bak, Martin, Lykkesfeldt, Anne E., Kirkegaard, Tove
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2015
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4338193/
https://ncbi.nlm.nih.gov/pubmed/25706943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0118346
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki